Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Start date: Feb 07, 2024 End date: Feb 09, 2024
Register Now!Join us for the International Stroke Conference 2024 in Phoenix, Arizona. This is your opportunity to:Network with fellow professionals.Stay updated on the latest treatments and scientific breakthroughs.Collaborate with global experts.Dive into discussions on brain health, stroke recovery, and more.Don't miss out! Register today and be part of ISC 2024.Find the online program planner… View more
Author(s): William McIntyre Added: 6 days ago
EHRA 24 - Investigator, Dr William McIntyre (Population Health Research Institute, CA) joins us to discuss the findings from a substudy of ARTESiA (NCT01938248).ARTESiA was a randomized, parallel assignment clinical trial which aimed to assess if apixaban could reduce the risk of ischemic stroke and systemic embolism in patients with subclinical atrial fibrillation (AF) and additional risk… View more
Author(s): Chi-Keong Ching , Reinhold Kreutz , Ian Phoon , et al Added: 3 years ago
Reproduced with permission from The Asia Pacific Society of Cardiology.Radcliffe have received no funding for the hosting of this content. View more
Author(s): Anne Alexandrov Added: 1 month ago
AHA ISC 2024 — Dr Anne Alexandrov (University of Tennessee Health Science Center, US) joins us to summarise the key findings from the Zero Degree Head Positioning in Hyperacute Large Artery Ischaemic Stroke (ZODIAC) trial (NCT03728738).ZODIAC is a prospective randomized open blinded endpoint (PROBE) clinical trial investigating head positioning in hyperacute LVO ischemic stroke treatment. It aims… View more
Author(s): A Michael Lincoff , Ahmed Ghoneem Added: 4 months ago
AHA 2023 - Investigator, Dr A Michael Lincoff (Cleveland Clinic, US) is interviewed by Dr Ahmed Ghoneem (UPMC Harrisburg, US), CardioNerds Ambassador, on the findings of the SELECT Trial (NCT03574597).SELECT is a randomised trial aiming to determine if semaglutide can reduce the risk of cardiovascular events in patients with overweight or obesity and prior cardiovascular disease. 17609 patients… View more
Author(s): Paul Wang Added: 1 year ago
AHA 22: Dr Paul Wang (Cardiac Arrhythmia Service at Palo Alto, Stanford, CA, US) joins us remotely to discuss the findings of the ENHANCE-AF trial, originally presented at the American Heart Association's 2022 Scientific Sessions. ENHANCE AF aimed to evaluate whether a shared-decision-making pathway tool would reduce the risk of stroke as a result of atrial fibrillation when compared to standard… View more
Job title: Professor of Stroke Medicine and Consultant Physician
Prof Jesse Dawson isProfessor of Stroke Medicine and Consultant Physician at the Queen Elizabeth University Hospital in Glasgow. His research portfolio includes prevention and rehabilitation clinical trials in stroke survivors, with main interest in improving the long-term outcome after stroke. Prof Dawson is the NHS Research Scotland lead for stroke research and sits on the editorial board of… View more
Job title: Professor of Neurology
Dr Shelagh Couttsis Professorof Neurology at The University of Calgary, Department of Clinical Neurosciences. Dr Couttsobtained her Undergraduate Medical Degree from the University of Edinburgh and undertook general medical training at Glasgow Royal Infirmary prior to specialising in neurology. She moved to Calgary to complete a Fellowship in Stroke Neurology with Dr Alastair Buchan and completed… View more